“Effectiveness and Safety of Anlotinib With or Without S-1 in the Treatment of Patients With Advanced Hepatocellular Carcinoma in Chinese Population: A Prospective, Phase 2 Study”. Radiology and Oncology 57, no. 3 (September 11, 2023): 405–410. Accessed September 23, 2026. https://radioloncol.com/index.php/ro/article/view/4122.